Graduate School of Biomedical Sciences
Alumni Association

Carolyn J. Foster, Ph.D.

Dr. Carolyn Foster currently works in Competitive Technical Intelligence at Boehringer Ingelheim Pharmaceuticals, an international pharmaceutical company headquartered in Ingelheim, Germany. She joined Boehringer in 2001 as a member of the Competitive Technical Intelligence Team with responsibility for autoimmune diseases.  Two years later, when cardiovascular research moved to the US from Germany, she added cardiovascular diseases to her responsibilities.  As a Competitive Technical Intelligence professional, she analyzes the external environment in the context of internal business issues, especially where technology is a factor.  Using scientific literature, news, websites, commercial and proprietary databases, and information gathered by attending scientific conferences, she tracks drug research and development in Pharma and Biotech. Her corporate clients include management of R&D, Licensing, Marketing and Medical and the scientists who support them.  In addition to Competitive Intelligence, she has recently taken on responsibility for managing external preclinical collaborations related to Boehringer’s marketed hypertension drugs, Micardis and Twynsta.

Prior to her Competitive Intelligence career, Dr. Foster worked at the Schering Plough Research Institute, first in analytical chemistry where she developed quality testing procedures for Schering Plough’s first biologic product, alpha interferon. Later, she worked as a biochemical pharmacologist in cardiovascular drug discovery, studying drugs to treat hypertension, atherosclerosis, thrombosis, and Parkinson’s disease.  Her published research focuses on G-protein coupled receptors and platelet function. 

Dr. Foster studied chemistry at Swarthmore College, received an M.S. in biochemistry from Brown University and a Ph.D. in pharmacology from the University of Medicine and Dentistry of New Jersey. She did post-doctoral research at the University of Pennsylvania in human genetics.  She is a Fellow of the New York Academy of Sciences where she has served as a member the conference planning committee, as Chair of the Biochemistry Section, and as head of the Biochemical Pharmacology Discussion Group (BPDG), an academia-industry consortium. She continues to be a member of the BPDG and regularly organizes symposia related to drug discovery.  She is a frequent speaker at Pharma Competitive Intelligence conferences.  In 2008, she was a finalist for the Connecticut Technology Council Women of Innovation Awards.